Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
Yahdiana Harahap,1 Puspitasari Ardiningsih,1 Agatha Corintias Winarti,1 Denni Joko Purwanto2 1Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia; 2Functional Medical Staff of Surgical Oncology, “Dharmais” Cancer Hospital, Jakarta, IndonesiaCorrespondence: Yahdiana Harah...
Saved in:
Main Authors: | Harahap Y (Author), Ardiningsih P (Author), Corintias Winarti A (Author), Purwanto DJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interaction of PUFAs and Doxorubicin: the Enhanced Toxicity in Breast Cancer Cells
by: Alicja Zajdel, et al.
Published: (2023) -
Doxorubicin-induced ovarian toxicity
by: Rizel Shulamith, et al.
Published: (2010) -
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
by: Zar Chi Soe, et al.
Published: (2019) -
Effects of Hyperbaric Oxygen Preconditioning on Doxorubicin Cardiorespiratory Toxicity
by: Vivian Doerr, et al.
Published: (2022) -
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016)